Brief: Viveve Medical says Proposed Changes To Study Design Of Pivotal Pursuit Trial Approved By U.S. FDA
10/12/2020 16:52
Dec 10 (Reuters) - Viveve Medical Inc VIVE.O :
* VIVEVE MEDICAL INC - PROPOSED CHANGES TO STUDY DESIGN OF
PIVOTAL PURSUIT TRIAL APPROVED BY U.S. FDA
Source text for Eikon: ID:
Further company coverage: VIVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viveve Medical
See all newsU.S. STOCKS ON THE MOVE-Chord Energy, Kroger, PetMed Express
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq